attend a Chongqing Brewery shareholders’ meeting shareholders holding a total of 266 million shares, against 260 million shares, accounting for voting 97.4% to 21.5747 million shares abstained, Dacheng Fund requires the removal of Huang Minggui motion was not passed. As for the research has been identified as failure of hepatitis B vaccine, Chongqing Brewery said, Next the company will be based on the summary report and Zhejiang combination of research and researchers team then decided to follow-up research and development process.
Chongqing Brewery shareholders’ meeting site
Finance, February 7
Finance, February 7A-shares in the history of the first fund company the emperor to abdicate drama finally came to an end.
February 6, at 12 o’clock, step on the perimeter, Dacheng Fund chief investment officer Liu, medical research, Lu Meng, and his party boarded the flight to Chongqing.about
Day 8, February 50, Chongqing Brewery shareholders ‘meeting, the door has been a police vehicle to maintain order in the shareholders’ meetings in over 300 venue has been arranged for 15 security guards to combat readiness.
9 30 points, including Chongqing Brewery chairman Huang Minggui, shareholders’ meeting host Carlsberg CEO Wang Keqin, four independent director, four supervisors, Chongqing Brewery aspects executives will all be present.70 shareholders
Dacheng Fund also will, on behalf of 26,556.6 million shares, accounting for 54.87%.
a confrontation of the emperor to abdicate drama will be waiting for the dripping staged.
encounters an active attitude: “very emotional” and “clear conscience”
the first to launch an attack on the shareholders of the venue, and questioned the finger of blame directly at Chongqing Brewery chairman Huang Minggui.the host Keqin read out before the shareholders’ meeting two motions, the Huang Minggui began to speak of “Ask yourself”.
Huang Minggui first announcement, suspension, 76 weeks of test data, test follow-up questions to do instructions. That all procedures are carried out according to state regulations, and insider trading issues such as self-examination. Huangming Gui said that the hepatitis B vaccine project is “very emotional”.
, Huang Minggui hepatitis B vaccine to the development of the company, Chongqing Brewery on the related process of hepatitis B vaccine is also in accordance with the relevant provisions were published; after November 27 last year, the company reports on the coordination and communication of relevant departments, striving to make things better, to fulfill responsibilities. “I have a clear conscience.”
clash response rates extraordinarily high to comment
has been the focal point of the high placebo response rate value of the focus, the Huang Minggui do the initial response.
Huang Minggui, Chongqing Brewery hepatitis B vaccine project technical director of one of the frontier is still the best e biological and said Frontier’s specialty is the “industry”, but Huang Minggui did not disclose the title and the work.
Chongqing Brewery shareholders on the authenticity of data, Huang Minggui response to the call through medical school, there is no evaluation of qualifications. Comfort group 28% of the issue, the scientific data to interpret the complex nature of interpretation should be conducted by experts on control group data high, experts are also being discussed. Throughout the trial, according to the national specification for the data, the final evaluation, only R & D team can make.
battle, freak, incrimination
The shareholders’ meeting of gunpowder in
on Huang Minggui explained from lit Dacheng Fund chief investment officer Liu.
Liu at the scene suddenly the initiative to apply to speak, to explain the grounds of the motion of the Dacheng Fund, including: December 8, 2011 announcement data is incomplete full, part of the data is not reasonable enough, causing the stock price plummeted; Dacheng Fund Disclosure Statement immediately the suspension of heavy beer, the company has paid no attention; letter Phi should be true and accurate and complete, and due diligence.again react
Huangming Gui, Huang Minggui said, the company run according to law, the disclosure of information that is no problem, there is no price manipulation intent.
battle four Buddha sleeve to leave
while listening to this interpretation, Dacheng Fund anger “down to the last.
Dacheng Fund pointed out that after the case, the Chongqing Beer unblinding key link in the vaccine project two of the submitted clinical summary report, to let investors make investment decisions, Dacheng Fund Huang Minggui for information disclosure, corporate governance norms The problem is responsible for.Da Cheng Fund
after while got up to leave that attitude, interpretation, and this emperor to abdicate drama to the climax, time, Dacheng Fund has put forward the motion to vote to dismiss Huang Minggui not yet started.
battle five, 98:2 culmination of defeat
results may be such as Dacheng Fund as early as expected, after their departure, shareholders voted to start.According to the results of a final vote, to attend the meeting of shareholders holding a total of 2.6659 million shares, against 258.7 million shares, accounting for vote 97.4353%, 21.5747 million shares abstained, Dacheng Fund requires the removal of Huang Minggui motion was not passed.
support Dacheng Fund in favor of the recall motion only 659.5099 million shares, accounting for only 2.4834%.
the end: follow-up vaccine R & D process to be determined
perhaps ending already doomed, but no matter where enough to express his attitude.13 years of the Black Swan event
Chongqing Brewery temporarily draw a full stop, the Huang Minggui continue to remain listed on the Chongqing Beer Company chairman, 61-year-old, he was in 2011 retiring Chongqing Beer Group chairman and party secretary positions.
Carlsberg side, then hire Yongtuo Certified Public Accountants Co., Ltd. Chongqing Brewery 2011 annual internal control audit institutions, “dealt with the audit” listen next time decomposition.The has been identified as the failure of the hepatitis B vaccine research, the Chongqing Brewery said, the next step the company will be based on the summary report and Zhejiang University combination with a team of researchers study, and then decided to follow-up research and development process, As for the end of the play This is enough. the
microblogging Live Record:
microblogging Watch Chongqing Brewery shareholders’ meetings
Carlsberg hire accountants audit the motion by
Dacheng Fund shareholders of Chongqing Brewery site, boomed
of Huang Minggui: placebo group value high personal unable to evaluate
: I very emotional on the hepatitis B vaccine project
beer at the shareholders meeting in Chongqing, the
Dacheng Fund did not vote would leave
chairman of the
heavy beer: Vaccine Project, a clear conscience that no manipulation of stock prices
Dacheng Fund: heavy beer letter Phi problems chairman Huang Minggui responsible for
NetEase statement: NetEase reproduced above for the purpose of transferring more information that confirmed the description or agree with their views. The article content is for reference only and does not constitute investment advice. Investors pursuant to operate your own risk.Fund News – the NetEase Channel